We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Explains How to Avoid ANDA Refusals for New Drug Strengths
FDA Explains How to Avoid ANDA Refusals for New Drug Strengths
Drugmakers submitting ANDAs for new drug strengths face FDA refusals due to insufficient justifications for impurities in the products, the agency says.